MONASH IVF GROUP LIMITED (MVF)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
MVF - MONASH IVF GROUP LIMITED
FNArena Sector :
Healthcare services
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.99
Index: ASX300 | ALL-ORDS
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.99
Monash IVF is an Australian provider of IVF, Ultrasound and genetic testing services throughout Australia and Asia. The company has been listed since 2014.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.52
07 May |
0.025 OPEN $1.50 |
1.67% HIGH $1.53 |
1,395,490 LOW $1.48 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
ACL . AHX . ALC . BMT . CAJ . DOC . EBO . HLS . M7T . MDR . MPL . NHF . PSQ . RHC . SHL . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | N/A | 7.6 | xxx |
DPS (cps) | xxx | N/A | 5.1 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | 20.0 | xxx |
Dividend Yield | xxx | N/A | 3.3% | xxx |
Div Pay Ratio(%) | xxx | N/A | 66.9% | xxx |
Last ex-div: 07/03 - ex-div 2.5c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 5.6 |
DPS All | xxx | xxx | xxx | xxx | xxx | 4.4 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 213.6 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 70.1 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 38.0 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 10.22 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 8.07 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 6.20 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 5.40 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 8.07 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 9.70 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -7.0 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 6 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 94 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 100 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 255 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 8 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.63 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 27.8 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 13.01 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 150 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 28 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 2 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
MVF STOCK CHART
FNArena News on MVF
1 |
Australian Broker Call *Extra* Edition – May 07, 2024May 07 2024 - Daily Market Reports |
2 |
ESG Focus: Governance, Supply Chains, RisksApr 29 2024 - ESG Focus |
3 |
ESG Focus: Counting Psychosocial Costs On ASXApr 22 2024 - ESG Focus |
4 |
Rudi’s View: Healthcare Under The ScannerMar 13 2024 - Rudi's View |
5 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 08-03-24Mar 08 2024 - Weekly Reports |
Latest Healthcare services News
1 |
Capitol Health’s Higher Margin OutlookMar 13 2024 - Small Caps |
2 |
Treasure Chest: Ramsay Health CareOct 26 2023 - Treasure Chest |
3 |
Timing Seems Right For Alcidion GroupJun 21 2023 - Small Caps |
4 |
No Enthusiasm To Combine ACL & HealiusMar 21 2023 - Australia |
5 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
6 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
7 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
8 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
9 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |
10 |
Ramsay Stakes Future on Mental HealthDec 20 2021 - Australia |